What essential knowledge about large‑vessel occlusion (LVO) should a medical student learn?

Essential Knowledge About Large Vessel Occlusion for Medical Students

Medical students must understand that large vessel occlusion (LVO) represents a stroke emergency requiring immediate recognition and treatment with mechanical thrombectomy, which has revolutionized outcomes when performed within specific time windows using strict eligibility criteria.

Definition and Epidemiology

LVO is the obstruction of major proximal cerebral arteries that accounts for approximately 18-19% of all acute ischemic strokes, though estimates vary widely in the literature 1. The most commonly affected vessels include:

• M1 segment of the middle cerebral artery (33% of LVOs) 1
• M2 segment of the MCA (27%) 1
• Internal carotid artery (17%) 1
• Tandem ICA-MCA lesions (11%) 1
• Less commonly: anterior cerebral artery, vertebral artery, basilar artery, and posterior cerebral artery 2

Despite using broad definitions of occlusion sites, the actual prevalence is lower than many earlier studies suggested, making accurate identification critical for resource allocation 1.

Clinical Recognition and Screening

NIHSS as the Foundation

The total NIHSS score ≥7 is the most reliable clinical predictor of LVO, with a positive predictive value of 84.2%, sensitivity of 81%, and specificity of 76.6% 3. However, this threshold still misses approximately 20% of LVO cases 3.

The most predictive individual NIHSS components for LVO are:

• Best gaze (odds ratio 9.6) 3
• Motor arm weakness (OR 7.6) 3
• Aphasia/neglect (OR 7.1) 3
• Visual field deficits (OR 7.0) 3

Prehospital Stroke Scales

Multiple specialized scales exist for LVO detection in the prehospital setting. The highest-performing scales include LARIO (AUC 0.983), FPSS (AUC 0.896), and FACE2AD (AUC 0.876) 4. For prehospital use specifically, FPSS, FAST VAN, and FACE2AD demonstrate the strongest performance 4.

Critical caveat: No clinical score can replace vessel imaging 3. Even the best-performing scales miss a substantial number of LVOs when clinically relevant thresholds are applied 3. Students must understand that clinical suspicion warrants immediate vascular imaging with CT angiography or MR angiography 5, 1.

Treatment: Mechanical Thrombectomy

Standard Time Window (0-6 Hours)

For patients with LVO in the ICA or proximal MCA (M1) presenting within 6 hours of symptom onset, mechanical thrombectomy is the standard of care 2. This applies regardless of whether IV thrombolysis is administered 6.

Key treatment principles:

• The technical goal is achieving mTICI 2b/3 reperfusion (modified Thrombolysis in Cerebral Infarction score), which maximizes functional outcomes 2
• Stent retrievers are the primary devices used 2
• Treatment can be offered with or without IV thrombolysis 6

Extended Time Window (6-24 Hours)

This represents a paradigm shift in stroke care. For carefully selected patients, thrombectomy can be performed up to 24 hours from last known normal 2, 6.

Strict eligibility criteria must be followed:

For 6-16 hour window (Class I recommendation):

• Must meet DAWN or DEFUSE-3 eligibility criteria 2
• DEFUSE-3 used perfusion-core mismatch and maximum core size on imaging 2
• Showed 44.6% vs 16.7% good outcomes (mRS 0-2) with treatment 2

For 16-24 hour window (Class IIa recommendation):

• Must meet DAWN eligibility criteria specifically 2
• DAWN used clinical-imaging mismatch (NIHSS score combined with CTP or DW-MRI findings) 2
• Demonstrated 49% vs 13% good outcomes (mRS 0-2) with treatment 2

Critical point: Only DAWN or DEFUSE-3 eligibility criteria should be used in clinical practice 2. These are the only randomized controlled trials demonstrating benefit beyond 6 hours, and their criteria must be strictly adhered to 2.

Special Populations and Situations

M2/M3 occlusions: Mechanical thrombectomy may be reasonable, though benefits are less certain than for proximal occlusions 2. Pooled data shows reperfusion is associated with excellent outcomes (OR 2.2) 2.

Posterior circulation occlusions: Thrombectomy may be reasonable for vertebral, basilar, anterior cerebral, or posterior cerebral artery occlusions within 6 hours, though benefits are uncertain 2.

Patients with pre-existing disability (baseline mRS 2-5): These patients were excluded from major trials but recent evidence shows EVT is safe and effective, with higher odds of returning to baseline function (OR 2.83) and no increased risk of symptomatic hemorrhage or mortality 7. Do not withhold thrombectomy based solely on pre-existing disability 7.

Patients with low NIHSS (<6), low ASPECTS (<6), or high baseline mRS (>1): Thrombectomy may be reasonable for ICA or M1 occlusions within 6 hours, though additional trial data are needed 2.

Imaging Considerations

CT angiography or MR angiography is mandatory for LVO confirmation 1. Advanced imaging with CT perfusion can provide additional prognostic information:

• CBV index (cerebral blood volume index) predicts futile recanalization 8
• CBV index <0.70 independently predicts poor outcomes despite successful reperfusion 8
• This marker reflects collateral circulation status and can guide treatment decisions 8

Common Pitfalls to Avoid

1. Relying solely on clinical scores without vascular imaging - even high NIHSS can miss LVOs, and imaging is required 3

2. Applying thrombectomy beyond 6 hours without meeting DAWN or DEFUSE-3 criteria - these strict criteria must be followed 2

3. Excluding patients with pre-existing disability - these patients can benefit significantly from EVT 7

4. Assuming all LVOs present with high NIHSS - presentation severity varies significantly by occlusion site 1

5. Delaying transfer to thrombectomy-capable centers - time is brain, and early identification with rapid triage is essential 6, 5